217 related articles for article (PubMed ID: 6438526)
21. Development and analysis of retroviral vectors expressing human factor VIII as a potential gene therapy for hemophilia A.
Chuah MK; VandenDriessche T; Morgan RA
Hum Gene Ther; 1995 Nov; 6(11):1363-77. PubMed ID: 8573610
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene.
Higuchi M; Kazazian HH; Kasch L; Warren TC; McGinniss MJ; Phillips JA; Kasper C; Janco R; Antonarakis SE
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7405-9. PubMed ID: 1908096
[TBL] [Abstract][Full Text] [Related]
23. Isolation of an active human transposable element.
Dombroski BA; Mathias SL; Nanthakumar E; Scott AF; Kazazian HH
Science; 1991 Dec; 254(5039):1805-8. PubMed ID: 1662412
[TBL] [Abstract][Full Text] [Related]
24. A DNA fragment from Xq21 replaces a deleted region containing the entire FVIII gene in a severe hemophilia A patient.
Murru S; Casula L; Casarino L; Moi P; Rocchi M; Loi A; Figus A; Mannella M; Poddie D; Kenwrick S
Genomics; 1994 Sep; 23(2):352-61. PubMed ID: 7835884
[TBL] [Abstract][Full Text] [Related]
25. Characteristic mRNA abnormality found in half the patients with severe haemophilia A is due to large DNA inversions.
Naylor J; Brinke A; Hassock S; Green PM; Giannelli F
Hum Mol Genet; 1993 Nov; 2(11):1773-8. PubMed ID: 8281136
[TBL] [Abstract][Full Text] [Related]
26. A standard nomenclature for factor VIII and factor IX gene mutations and associated amino acid alterations. On behalf of the ISTH SSC Subcommittee on Factor VIII and Factor IX.
Peake I; Tuddenham E
Thromb Haemost; 1994 Sep; 72(3):475-6. PubMed ID: 7855800
[No Abstract] [Full Text] [Related]
27. Genetic control of factor VIII.
Graham JB
Lancet; 1980 Feb; 1(8164):340-2. PubMed ID: 6101793
[No Abstract] [Full Text] [Related]
28. [Recombinant factor VIII].
Tusell JM
Sangre (Barc); 1993 Apr; 38(2):139-42. PubMed ID: 8516727
[No Abstract] [Full Text] [Related]
29. Expression of biologically active human factor VIII using a baculovirus vector.
Webb E; Tkalcevic J; Edwards S; Hocking D; Nisbet I
Biochem Biophys Res Commun; 1993 Jan; 190(2):536-43. PubMed ID: 8427596
[TBL] [Abstract][Full Text] [Related]
30. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A.
Bi L; Lawler AM; Antonarakis SE; High KA; Gearhart JD; Kazazian HH
Nat Genet; 1995 May; 10(1):119-21. PubMed ID: 7647782
[TBL] [Abstract][Full Text] [Related]
31. Factors impeding efficient expression of factor VIII complementary DNA minigenes.
Hoeben RC; Fallaux FJ; Schagen FH; van der Eb MM; van Ormondt H; van der Eb A
Blood Coagul Fibrinolysis; 1997 Dec; 8 Suppl 2():S15-21. PubMed ID: 9607109
[TBL] [Abstract][Full Text] [Related]
32. Sequence of the human factor VIII-associated gene is conserved in mouse.
Levinson B; Bermingham JR; Metzenberg A; Kenwrick S; Chapman V; Gitschier J
Genomics; 1992 Jul; 13(3):862-5. PubMed ID: 1639415
[TBL] [Abstract][Full Text] [Related]
33. cDNA cloning of a mouse mammary epithelial cell surface protein reveals the existence of epidermal growth factor-like domains linked to factor VIII-like sequences.
Stubbs JD; Lekutis C; Singer KL; Bui A; Yuzuki D; Srinivasan U; Parry G
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8417-21. PubMed ID: 2122462
[TBL] [Abstract][Full Text] [Related]
34. [Intragenic variable number tandom repeats in coagulation factor VIII gene of Chinese origin].
Wang XD
Zhonghua Yi Xue Za Zhi; 1993 Apr; 73(4):206-8, 252. PubMed ID: 8395312
[TBL] [Abstract][Full Text] [Related]
35. Mutation detection in factor VIII cDNA from lymphocytes of hemophilia A patients by solid phase fluorescent chemical cleavage of mismatch.
Waseem NH; Bagnall R; Green PM; Giannelli F
Methods Mol Biol; 2002; 187():109-23. PubMed ID: 12013738
[No Abstract] [Full Text] [Related]
36. [Structure and function of factor VIII and factor IX gene and molecular DNA diagnosis in hemophilia A and B].
Herrmann FH; Wehnert M; Wulff K
Z Arztl Fortbild (Jena); 1988; 82(22):1116-22. PubMed ID: 2907834
[No Abstract] [Full Text] [Related]
37. A new recombinant factor VIII: from genetics to clinical use.
Santagostino E
Drug Des Devel Ther; 2014; 8():2507-15. PubMed ID: 25548513
[TBL] [Abstract][Full Text] [Related]
38. Hemophilia A. Detection of molecular defects and of carriers by DNA analysis.
Antonarakis SE; Waber PG; Kittur SD; Patel AS; Kazazian HH; Mellis MA; Counts RB; Stamatoyannopoulos G; Bowie EJ; Fass DN
N Engl J Med; 1985 Oct; 313(14):842-8. PubMed ID: 2993888
[TBL] [Abstract][Full Text] [Related]
39. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A.
Hsu HC; Chen YF; Ho CH
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jul; 62(7):450-4. PubMed ID: 10418180
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetics of coagulation factor VIII gene and hemophilia A.
Antonarakis SE
Thromb Haemost; 1995 Jul; 74(1):322-8. PubMed ID: 8578479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
